Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Nutr ; 38(3): 1012-1022, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30274898

RESUMO

BACKGROUND & AIMS: This review examines to what extent high-protein diets (HPD), which may favor body weight loss and improve metabolic outcomes in overweight and obese individuals, may also impact the gut environment, shaping the microbiota and the host-microbe (co)metabolic pathways and products, possibly affecting large intestine mucosa homeostasis. METHODS: PubMed-referenced publications were analyzed with an emphasis on dietary intervention studies involving human volunteers in order to clarify the beneficial vs. deleterious effects of HPD in terms of both metabolic and gut-related health parameters; taking into account the interactions with the gut microbiota. RESULTS: HPD generally decrease body weight and improve blood metabolic parameters, but also modify the fecal and urinary contents in various bacterial metabolites and co-metabolites. The effects of HPD on the intestinal microbiota composition appear rather heterogeneous depending on the type of dietary intervention. Recently, HPD consumption was shown to modify the expression of genes playing key roles in homeostatic processes in the rectal mucosa, without evidence of intestinal inflammation. Importantly, the effects of HPD on the gut were dependent on the protein source (i.e. from plant or animal sources), a result which should be considered for further investigations. CONCLUSION: Although HPD appear to be efficient for weight loss, the effects of HPD on microbiota-derived metabolites and gene expression in the gut raise new questions on the impact of HPD on the large intestine mucosa homeostasis leading the authors to recommend some caution regarding the utilization of HPD, notably in a recurrent and/or long-term ways.


Assuntos
Dieta Rica em Proteínas , Dieta , Microbioma Gastrointestinal , Redução de Peso , Peso Corporal/fisiologia , Humanos , Mucosa Intestinal/microbiologia , Mucosa Intestinal/fisiologia , Intestino Grosso/microbiologia , Intestino Grosso/fisiologia
2.
Am J Clin Nutr ; 106(4): 1005-1019, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28903954

RESUMO

Background: Although high-protein diets (HPDs) are frequently consumed for body-weight control, little is known about the consequences for gut microbiota composition and metabolic activity and for large intestine mucosal homeostasis. Moreover, the effects of HPDs according to the source of protein need to be considered in this context.Objective: The objective of this study was to evaluate the effects of the quantity and source of dietary protein on microbiota composition, bacterial metabolite production, and consequences for the large intestinal mucosa in humans.Design: A randomized, double-blind, parallel-design trial was conducted in 38 overweight individuals who received a 3-wk isocaloric supplementation with casein, soy protein, or maltodextrin as a control. Fecal and rectal biopsy-associated microbiota composition was analyzed by 16S ribosomal DNA sequencing. Fecal, urinary, and plasma metabolomes were assessed by 1H-nuclear magnetic resonance. Mucosal transcriptome in rectal biopsies was determined with the use of microarrays.Results: HPDs did not alter the microbiota composition, but induced a shift in bacterial metabolism toward amino acid degradation with different metabolite profiles according to the protein source. Correlation analysis identified new potential bacterial taxa involved in amino acid degradation. Fecal water cytotoxicity was not modified by HPDs, but was associated with a specific microbiota and bacterial metabolite profile. Casein and soy protein HPDs did not induce inflammation, but differentially modified the expression of genes playing key roles in homeostatic processes in rectal mucosa, such as cell cycle or cell death.Conclusions: This human intervention study shows that the quantity and source of dietary proteins act as regulators of gut microbiota metabolite production and host gene expression in the rectal mucosa, raising new questions on the impact of HPDs on the large intestine mucosa homeostasis. This trial was registered at clinicaltrials.gov as NCT02351297.


Assuntos
Bactérias/metabolismo , Dieta com Restrição de Carboidratos , Proteínas Alimentares/farmacologia , Microbioma Gastrointestinal , Mucosa Intestinal/metabolismo , Intestino Grosso/metabolismo , Transcriptoma , Adulto , Aminoácidos/metabolismo , Bactérias/genética , Caseínas/farmacologia , DNA Bacteriano/análise , Proteínas Alimentares/administração & dosagem , Proteínas Alimentares/metabolismo , Método Duplo-Cego , Fezes , Feminino , Homeostase , Humanos , Mucosa Intestinal/microbiologia , Intestino Grosso/microbiologia , Masculino , Obesidade/dietoterapia , RNA Ribossômico 16S , Reto/metabolismo , Reto/microbiologia , Proteínas de Soja/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...